Pharmacovigilance Risk Assessment Committee (PRAC): 13-16 January 2025, European Medicines Agency, Amsterdam, the Netherlands, from 13 January 2025 to 16 January 2025

Pharmacovigilance Risk Assessment Committee (PRAC): 13-16 January 2025, European Medicines Agency, Amsterdam, the Netherlands, from 13 January 2025 to 16 January 2025

Human medicines European public assessment report (EPAR): Pepaxti, melphalan flufenamide, Date of authorisation: 17/08/2022, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Pepaxti, melphalan flufenamide, Date of authorisation: 17/08/2022, Revision: 5, Status: Authorised

Procedure for the preparation of European Union herbal monographs and European Union list entries and appointment of HMPC rapporteurs and peer-reviewers

Procedure for the preparation of European Union herbal monographs and European Union list entries and appointment of HMPC rapporteurs and peer-reviewers

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness